Literature DB >> 26878983

Normalization of doxorubicin release from graphene oxide: New approach for optimization of effective parameters on drug loading.

Mohadeseh Hashemi1,2, Amir Yadegari1, Ghasem Yazdanpanah1, Meisam Omidi1, Sayena Jabbehdari1, Fatemeh Haghiralsadat2, Fatemeh Yazdian2, Lobat Tayebi3,4.   

Abstract

Graphene oxide (GO) has been recently introduced as a suitable anticancer drug carrier, which could be loaded with doxorubicin (DOX) as a general chemotherapy agent. Herein, the attempts were made to optimize the effective parameters on both loading and release of DOX on GO. GO and GO-DOX were characterized using transition electron microscopy , zeta potential, Raman spectroscopy, UV-visible spectroscopy, and Fourier transform infrared spectroscopy. In addition, loading and releasing behaviors of DOX on GO were studied in terms of different temperature and pH values. The primary optimized values of pH and temperature for best-loaded amount of DOX were 8.9 and 309 K, respectively. Moreover, we found that the smallest amount of released DOX, in pH of cancer microenvironment (5.4), occurs when DOX had been previously loaded in pH 7.8 and 310 K. Although the highest amount of loaded DOX was in basic pH, the results of efficient release of DOX from the GO-DOX complex and also cellular toxicity assay revealed that the best pH for loading of DOX on GO was 7.8. Therefore, in addition to optimization of parameters for efficient loading of DOX on GO, this study suggested that normalization of a released drug compared with the amount of a loaded drug could be a new approach for optimization of drug loading on nanocarriers.
© 2016 International Union of Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  doxorubicin; drug delivery; graphene oxide; loading and releasing behavior

Mesh:

Substances:

Year:  2016        PMID: 26878983     DOI: 10.1002/bab.1487

Source DB:  PubMed          Journal:  Biotechnol Appl Biochem        ISSN: 0885-4513            Impact factor:   2.431


  2 in total

1.  Graphene-based hybrid nanoparticle of doxorubicin for cancer chemotherapy.

Authors:  Nagaraja SreeHarsha; Rahul Maheshwari; Bandar E Al-Dhubiab; Muktika Tekade; Mukesh Chandra Sharma; Katharigatta N Venugopala; Rakesh Kumar Tekade; Abdullah M Alzahrani
Journal:  Int J Nanomedicine       Date:  2019-09-12

Review 2.  Nanomedicine-Based Delivery Strategies for Breast Cancer Treatment and Management.

Authors:  Priti Tagde; Agnieszka Najda; Kalpana Nagpal; Giriraj T Kulkarni; Muddaser Shah; Obaid Ullah; Sebastian Balant; Md Habibur Rahman
Journal:  Int J Mol Sci       Date:  2022-03-05       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.